Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · October 06, 2023

Long-Term Safety of Tenapanor Therapy in Patients With IBS With Constipation

Neurogastroenterology and Motility


Additional Info

Neurogastroenterology and Motility
Long-term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO-3 study
Neurogastroenterol. Motil. 2023 Sep 05;[EPub Ahead of Print], AJ Lembo, KA Friedenberg, RP Fogel, S Edelstein, S Zhao, Y Yang, DP Rosenbaum, WD Chey

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading